cloudfront
  • info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) | +1-214-736-7666 (US) | +1-740-994-0111 (US)
  • Sign In
  • Register

Report Detail



OtherGlobal Endometriosis Therapies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2541486
  • |
  • 5 November, 2018
  • |
  • Global
  • |
  • 119 pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month

Scope of the Report:

The worldwide market for Endometriosis Therapies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Endometriosis Therapies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

AbbVie

Eli Lilly

AstraZeneca

Bayer

Astellas Pharma

Meditrina Pharmaceuticals

Pfizer

Neurocrine Biosciences

Takeda Pharmaceutical

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Hormonal Contraceptives

Gonadotropin-releasing Hormone (Gn-RH) Agonists 

Progestin Therapy

Aromatase Inhibitors

Market Segment by Applications, can be divided into

Hospital

Clinic

Other

There are 15 Chapters to deeply display the global Endometriosis Therapies market.

Chapter 1, to describe Endometriosis Therapies Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Endometriosis Therapies, with sales, revenue, and price of Endometriosis Therapies, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Endometriosis Therapies, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Endometriosis Therapies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Endometriosis Therapies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

1 Market Overview

1.1 Endometriosis Therapies Introduction

1.2 Market Analysis by Type

1.2.1 Hormonal Contraceptives

1.2.2 Gonadotropin-releasing Hormone (Gn-RH) Agonists 

1.2.3 Progestin Therapy

1.2.4 Aromatase Inhibitors

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Clinic

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 AbbVie

2.1.1 Business Overview

2.1.2 Endometriosis Therapies Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AbbVie Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Eli Lilly

2.2.1 Business Overview

2.2.2 Endometriosis Therapies Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Eli Lilly Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 AstraZeneca

2.3.1 Business Overview

2.3.2 Endometriosis Therapies Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 AstraZeneca Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Bayer

2.4.1 Business Overview

2.4.2 Endometriosis Therapies Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Bayer Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Astellas Pharma

2.5.1 Business Overview

2.5.2 Endometriosis Therapies Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Astellas Pharma Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Meditrina Pharmaceuticals

2.6.1 Business Overview

2.6.2 Endometriosis Therapies Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Endometriosis Therapies Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Neurocrine Biosciences

2.8.1 Business Overview

2.8.2 Endometriosis Therapies Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Neurocrine Biosciences Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Takeda Pharmaceutical

2.9.1 Business Overview

2.9.2 Endometriosis Therapies Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Takeda Pharmaceutical Endometriosis Therapies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Endometriosis Therapies Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Endometriosis Therapies Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Endometriosis Therapies Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Endometriosis Therapies Manufacturer Market Share in 2017

3.3.2 Top 6 Endometriosis Therapies Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Endometriosis Therapies Market Analysis by Regions

4.1 Global Endometriosis Therapies Sales, Revenue and Market Share by Regions

4.1.1 Global Endometriosis Therapies Sales and Market Share by Regions (2013-2018)

4.1.2 Global Endometriosis Therapies Revenue and Market Share by Regions (2013-2018)

4.2 North America Endometriosis Therapies Sales and Growth Rate (2013-2018)

4.3 Europe Endometriosis Therapies Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Endometriosis Therapies Sales and Growth Rate (2013-2018)

4.5 South America Endometriosis Therapies Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Endometriosis Therapies Sales and Growth Rate (2013-2018)

5 North America Endometriosis Therapies by Countries

5.1 North America Endometriosis Therapies Sales, Revenue and Market Share by Countries

5.1.1 North America Endometriosis Therapies Sales and Market Share by Countries (2013-2018)

5.1.2 North America Endometriosis Therapies Revenue and Market Share by Countries (2013-2018)

5.2 United States Endometriosis Therapies Sales and Growth Rate (2013-2018)

5.3 Canada Endometriosis Therapies Sales and Growth Rate (2013-2018)

5.4 Mexico Endometriosis Therapies Sales and Growth Rate (2013-2018)

6 Europe Endometriosis Therapies by Countries

6.1 Europe Endometriosis Therapies Sales, Revenue and Market Share by Countries

6.1.1 Europe Endometriosis Therapies Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Endometriosis Therapies Revenue and Market Share by Countries (2013-2018)

6.2 Germany Endometriosis Therapies Sales and Growth Rate (2013-2018)

6.3 UK Endometriosis Therapies Sales and Growth Rate (2013-2018)

6.4 France Endometriosis Therapies Sales and Growth Rate (2013-2018)

6.5 Russia Endometriosis Therapies Sales and Growth Rate (2013-2018)

6.6 Italy Endometriosis Therapies Sales and Growth Rate (2013-2018)

7 Asia-Pacific Endometriosis Therapies by Countries

7.1 Asia-Pacific Endometriosis Therapies Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Endometriosis Therapies Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Endometriosis Therapies Revenue and Market Share by Countries (2013-2018)

7.2 China Endometriosis Therapies Sales and Growth Rate (2013-2018)

7.3 Japan Endometriosis Therapies Sales and Growth Rate (2013-2018)

7.4 Korea Endometriosis Therapies Sales and Growth Rate (2013-2018)

7.5 India Endometriosis Therapies Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Endometriosis Therapies Sales and Growth Rate (2013-2018)

8 South America Endometriosis Therapies by Countries

8.1 South America Endometriosis Therapies Sales, Revenue and Market Share by Countries

8.1.1 South America Endometriosis Therapies Sales and Market Share by Countries (2013-2018)

8.1.2 South America Endometriosis Therapies Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Endometriosis Therapies Sales and Growth Rate (2013-2018)

8.3 Argentina Endometriosis Therapies Sales and Growth Rate (2013-2018)

8.4 Colombia Endometriosis Therapies Sales and Growth Rate (2013-2018)

9 Middle East and Africa Endometriosis Therapies by Countries

9.1 Middle East and Africa Endometriosis Therapies Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Endometriosis Therapies Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Endometriosis Therapies Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Endometriosis Therapies Sales and Growth Rate (2013-2018)

9.3 UAE Endometriosis Therapies Sales and Growth Rate (2013-2018)

9.4 Egypt Endometriosis Therapies Sales and Growth Rate (2013-2018)

9.5 Nigeria Endometriosis Therapies Sales and Growth Rate (2013-2018)

9.6 South Africa Endometriosis Therapies Sales and Growth Rate (2013-2018)

10 Global Endometriosis Therapies Market Segment by Type

10.1 Global Endometriosis Therapies Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Endometriosis Therapies Sales and Market Share by Type (2013-2018)

10.1.2 Global Endometriosis Therapies Revenue and Market Share by Type (2013-2018)

10.2 Hormonal Contraceptives Sales Growth and Price

10.2.1 Global Hormonal Contraceptives Sales Growth (2013-2018)

10.2.2 Global Hormonal Contraceptives Price (2013-2018)

10.3 Gonadotropin-releasing Hormone (Gn-RH) Agonists  Sales Growth and Price

10.3.1 Global Gonadotropin-releasing Hormone (Gn-RH) Agonists  Sales Growth (2013-2018)

10.3.2 Global Gonadotropin-releasing Hormone (Gn-RH) Agonists  Price (2013-2018)

10.4 Progestin Therapy Sales Growth and Price

10.4.1 Global Progestin Therapy Sales Growth (2013-2018)

10.4.2 Global Progestin Therapy Price (2013-2018)

10.5 Aromatase Inhibitors Sales Growth and Price

10.5.1 Global Aromatase Inhibitors Sales Growth (2013-2018)

10.5.2 Global Aromatase Inhibitors Price (2013-2018)

11 Global Endometriosis Therapies Market Segment by Application

11.1 Global Endometriosis Therapies Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Clinic Sales Growth (2013-2018)

11.4 Other Sales Growth (2013-2018)

12 Endometriosis Therapies Market Forecast (2018-2023)

12.1 Global Endometriosis Therapies Sales, Revenue and Growth Rate (2018-2023)

12.2 Endometriosis Therapies Market Forecast by Regions (2018-2023)

12.2.1 North America Endometriosis Therapies Market Forecast (2018-2023)

12.2.2 Europe Endometriosis Therapies Market Forecast (2018-2023)

12.2.3 Asia-Pacific Endometriosis Therapies Market Forecast (2018-2023)

12.2.4 South America Endometriosis Therapies Market Forecast (2018-2023)

12.2.5 Middle East and Africa Endometriosis Therapies Market Forecast (2018-2023)

12.3 Endometriosis Therapies Market Forecast by Type (2018-2023)

12.3.1 Global Endometriosis Therapies Sales Forecast by Type (2018-2023)

12.3.2 Global Endometriosis Therapies Market Share Forecast by Type (2018-2023)

12.4 Endometriosis Therapies Market Forecast by Application (2018-2023)

12.4.1 Global Endometriosis Therapies Sales Forecast by Application (2018-2023)

12.4.2 Global Endometriosis Therapies Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Endometriosis Therapies . Industry analysis & Market Report on Endometriosis Therapies is a syndicated market report, published as Global Endometriosis Therapies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Endometriosis Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,480.00
$5,220.00
$6,960.00
2,336.82
3,505.23
4,673.64
3,202.30
4,803.44
6,404.59
421,567.20
632,350.80
843,134.40
230,770.63
346,155.95
461,541.26
Add To Cart Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report